Skip to main content

Gem Investment Advisors, LLC

SEC CIK
0001580018
Latest filing
Aug 10, 2026

The latest 13F from Gem Investment Advisors, LLC covers Q2 2026 (filed Aug 10, 2026): 35 long positions worth $163.0M. The top 10 holdings make up 80.1% of the portfolio, and the largest is Garrett Motion Inc. (GTX) at 22.1%. Livermore has 3 filings on Form 13F from this institution, going back to Q4 2025.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
2
Est. +$2.06M
Added
7
Est. +$24.1M
Reduced
7
Est. −$5.60M
Sold out
1
Est. −$2.36M

Top 5 holdings

Share of this quarter's portfolio value

  1. GTXGarrett Motion Inc.
    22.1%$36.0MHistory
  2. ABSIAbsci Corp
    15.4%$25.2MHistory
  3. DRTSAlpha Tau Medical Ltd.
    11.1%$18.0MHistory
  4. QDELQuidelOrtho Corp
    6.1%$9.91MHistory
  5. ORMPOramed Pharmaceuticals Inc.
    5.9%$9.61MHistory

Share of portfolio

Top 5 holdings and the other 30 positions, by share of portfolio value

  1. GTX22.1%
  2. ABSI15.4%
  3. DRTS11.1%
  4. QDEL6.1%
  5. ORMP5.9%
  6. Other 30 positions39.4%

Biggest buys

New and added positions, by estimated amount bought

  1. DRTSAlpha Tau Medical Ltd.
    +$16.6MAddedHistory
  2. QDELQuidelOrtho Corp
    +$4.72MAddedHistory
  3. ORMPOramed Pharmaceuticals Inc.
    +$1.73MAddedHistory
  4. NNDMNano Dimension Ltd.
    +$1.45MNewHistory
  5. ABEOAbeona Therapeutics Inc.
    +$612.3KNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. DRTSAlpha Tau Medical Ltd.
    +10.28 pp0.8% → 11.1%History
  2. QDELQuidelOrtho Corp
    +1.29 pp4.8% → 6.1%History
  3. NNDMNano Dimension Ltd.
    +0.89 pp0.0% → 0.9%History
  4. ORMPOramed Pharmaceuticals Inc.
    +0.41 pp5.5% → 5.9%History
  5. ABEOAbeona Therapeutics Inc.
    +0.38 pp0.0% → 0.4%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. BTCGrayscale Bitcoin Mini Trust ETF
    −$2.70MReducedHistory
  2. FBTCFidelity Wise Origin Bitcoin Fund
    −$2.36MSold outHistory
  3. LRMRLarimar Therapeutics, Inc.
    −$1.63MReducedHistory
  4. GTXGarrett Motion Inc.
    −$811.8KReducedHistory
  5. SHCSotera Health Co
    −$230.7KReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. BTCGrayscale Bitcoin Mini Trust ETF
    −3.63 pp4.3% → 0.7%History
  2. LRMRLarimar Therapeutics, Inc.
    −3.18 pp3.8% → 0.6%History
  3. FBTCFidelity Wise Origin Bitcoin Fund
    −2.32 pp2.3% → 0.0%History
  4. SHCSotera Health Co
    −1.19 pp4.6% → 3.4%History
  5. SEGSeaport Entertainment Group Inc.
    −0.17 pp0.6% → 0.5%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$163.0M
+$61.3M (+60.3%) vs. prior quarter
Positions
35
+1 vs. prior quarter
Top 10 concentration
80.1%
Top 10 as share of value
Turnover
6.0%
Q2 2026, one quarter
Average holding period
2.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2025), so positions held before then are understated.

13F filings by quarter

3 quarters, going back to Q4 2025. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $163.0M (Q2 2026)

Q4 2025: $105.5MQ1 2026: $101.7MQ2 2026: $163.0M
Q4 2025Q2 2026
13F filings of Gem Investment Advisors, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 10, 202635$163.0MGTXABSIDRTSvs. Q1 2026SEC
Q1 2026May 15, 202634$101.7MGTXCEFABSIvs. Q4 2025SEC
Q4 2025May 15, 202631$105.5MGTXECHOCEF–SEC

13D and 13G filings

Companies where Gem Investment Advisors, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

1 company, largest stake first.

Companies where Gem Investment Advisors, LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
PRKRParkervision Inc13G/A9.99%15.2M shares0.00 ppfrom 9.99%Mar 9, 20216 filingsMay 19, 2026SEC

Latest filings

6 filings on file made by Gem Investment Advisors, LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Gem Investment Advisors, LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
PRKRParkervision IncMay 19, 20269:30 AM ET13G/A9.99%15.2M shares0.00 ppfrom 9.99%Mar 31, 2026SEC
PRKRParkervision IncMay 12, 202512:32 PM ET13G/A9.99%11.7M shares–Mar 31, 2025SEC
PRKRParkervision IncFeb 28, 202413G/AOld format–––SEC
PRKRParkervision IncFeb 13, 202313G/AOld format–––SEC
PRKRParkervision IncAug 11, 202213G/AOld format–––SEC
PRKRParkervision IncMar 9, 202113G/AOld format–––SEC